TY - JOUR
T1 - Cancer mortality and incidence following external occupational radiation exposure
T2 - an update of the 3rd analysis of the UK national registry for radiation workers
AU - Haylock, Richard
AU - Gillies, Michael
AU - Hunter, Nezahat
AU - Zhang, Wei
AU - Phillipson, Mary
N1 - Publisher Copyright:
© 2018, The Author(s).
PY - 2018/8/28
Y1 - 2018/8/28
N2 - Background: This study provides direct evidence of cancer risk from low dose and dose rate occupational external radiation exposures. Methods: Cancer mortality and incidence were studied in relation to external radiation exposure in the National Registry for Radiation Workers. A cohort of 167,003 workers followed for an average of 32 years was analysed using Poisson regression methods. Results: Mortality and incidence risks were significantly raised for the group of all malignant neoplasms excluding leukaemia (ERR/Sv mortality = 0.28; 90%CI: 0.06, 0.53, ERR/Sv incidence = 0.28; 90%CI: 0.10, 0.48) but with narrower confidence bounds compared with the previous analysis of this cohort reflecting the increased statistical power from the additional 10 years of follow-up information. The linear trends in relative risk for both mortality and incidence of these cancers remained statistically significantly raised when information relating to cumulative doses above 100 mSv was excluded (ERR/Sv mortality = 1.42; 90%CI: 0.51, 2.38 and ERR/Sv incidence = 1.18; 90%CI: 0.47, 1.92). Conclusions: This study improved the precision of the cancer risk estimates seen in the third analysis of the NRRW cohort. The overall results remain consistent with the risk estimates from the Life Span Study and those adopted in the current ICRP recommendations.
AB - Background: This study provides direct evidence of cancer risk from low dose and dose rate occupational external radiation exposures. Methods: Cancer mortality and incidence were studied in relation to external radiation exposure in the National Registry for Radiation Workers. A cohort of 167,003 workers followed for an average of 32 years was analysed using Poisson regression methods. Results: Mortality and incidence risks were significantly raised for the group of all malignant neoplasms excluding leukaemia (ERR/Sv mortality = 0.28; 90%CI: 0.06, 0.53, ERR/Sv incidence = 0.28; 90%CI: 0.10, 0.48) but with narrower confidence bounds compared with the previous analysis of this cohort reflecting the increased statistical power from the additional 10 years of follow-up information. The linear trends in relative risk for both mortality and incidence of these cancers remained statistically significantly raised when information relating to cumulative doses above 100 mSv was excluded (ERR/Sv mortality = 1.42; 90%CI: 0.51, 2.38 and ERR/Sv incidence = 1.18; 90%CI: 0.47, 1.92). Conclusions: This study improved the precision of the cancer risk estimates seen in the third analysis of the NRRW cohort. The overall results remain consistent with the risk estimates from the Life Span Study and those adopted in the current ICRP recommendations.
UR - http://www.scopus.com/inward/record.url?scp=85052500620&partnerID=8YFLogxK
U2 - 10.1038/s41416-018-0184-9
DO - 10.1038/s41416-018-0184-9
M3 - Article
C2 - 30108294
AN - SCOPUS:85052500620
SN - 0007-0920
VL - 119
SP - 631
EP - 637
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 5
ER -